Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26889 of the 27780 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,576–5,600 of 27,780 studies, newest first · page 224 of 1112.

January 2025 25

  1. 2025-01-15

    Long-Term Intake of Red Meat in Relation to Dementia Risk and Cognitive Function in US Adults

    ✓ Peer-reviewed Prevention and risk Neurology

    Key finding: Replacing 1 serving per day of nuts and legumes for processed red meat was associated with a 19% lower risk of dementia (HR 0.81, 95% CI 0.75-0.86), 1.37 fewer years of cognitive aging (95% CI -2.49 to -0.25), and a 21% lower risk of SCD (RR 0.79, 95% CI 0.68-0.92). +3 more findings

  2. 2025-01-15

    Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data

    ✓ Peer-reviewed Risk factors PLoS ONE

    Key finding: Levels of underdiagnosis varied between 16% for stroke and 69% for prostate cancer in 2018. +4 more findings

  3. 2025-01-14

    Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Risk stratification for PET Aβ+ based on a plasma p-tau217 assay demonstrated potential diagnostic and prognostic utility in an Asian cohort with concomitant CeVD. +3 more findings

  4. 2025-01-14

    Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

    ✓ Peer-reviewed Biomarkers The journal of prevention of Alzheimer's disease

    Key finding: Despite the high performance and robustness demonstrated in research, plasma p-tau217, like all plasma biomarkers, can be affected by analytical and pre-analytical variability as well as patient comorbidities, sex, ethnicity, and race.

  5. 2025-01-14

    Dementia Diagnosis Unawareness and Caregiver Burden in a Multi-ethnic Cohort

    ✓ Peer-reviewed Caregiving Journal of general internal medicine

    Key finding: Eighty-one percent of eligible participants were not aware of a dementia diagnosis. +4 more findings

  6. 2025-01-14

    Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy

    ✓ Peer-reviewed Brain tissue and pathology Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Alternatively, when present with ADNC, LATE-NC is associated with a more rapid course.

  7. 2025-01-14

    The immunology of stroke and dementia

    ✓ Peer-reviewed Treatments Immunity

    Key finding: Ischemic stroke and vascular cognitive impairment, caused by a sudden arterial occlusion or more subtle but protracted vascular insufficiency, respectively, are leading causes of morbidity and mortality worldwide with limited therapeutic options. +3 more findings

  8. 2025-01-14

    Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities

    ✓ Peer-reviewed Disease mechanisms Communications Biology

    Key finding: Our results indicate that the aBDTOs possess different structural and morphological features that impact neuronal function, gene regulation, and ultimately disease progression. +1 more finding

  9. 2025-01-14

    The association of seizure control with neuropathology in dementia

    ✓ Peer-reviewed Long-term cohort studies Brain

    Key finding: Seizures in people with dementia (PWD) are associated with faster cognitive decline and worse clinical outcomes. +2 more findings

  10. 2025-01-14
  11. 2025-01-14

    Avanços em biomarcadores plasmáticos e do líquido cefalorraquidiano para a detecção precoce da doença de Alzheimer

    ✓ Peer-reviewed Tau biomarkers Brazilian Journal of Health Review

    Key finding: A pesquisa destacou a importância de biomarcadores como p-tau e β-amiloide no diagnóstico precoce e acompanhamento da Doença de Alzheimer (DA). +4 more findings

  12. 2025-01-14

    Modifiable risk factors for early- and late-onset dementia using the Korean national health insurance service database

    ✓ Peer-reviewed Risk factors The Journal of Prevention of Alzheimer s Disease

    Key finding: Higher socioeconomic status and increased frequency of physical activity were associated with a lower risk of both EOD and LOD. +4 more findings

  13. 2025-01-14

    Cardiometabolic Multimorbidity and Dementia Onset Among Middle-Aged and Older Adults: Differences by Race/Ethnicity

    ✓ Peer-reviewed Disparities The Journals of Gerontology Series A

    Key finding: Over a mean follow-up of 14.6 years, 7.7% of the participants (n = 614) developed dementia. +4 more findings

  14. 2025-01-14

    An evaluation of a community dementia screening program in rural Kenya: DEM‐SKY

    ✓ Peer-reviewed Disparities Alzheimer s & Dementia

    Key finding: The program demonstrated good acceptability, adoption, and fidelity and was effective in instigating behavior change. +4 more findings

  15. 2025-01-14
  16. 2025-01-14
  17. 2025-01-14
  18. 2025-01-13

    Pathways to Racial/Ethnic Inequalities in Dementia

    ✓ Peer-reviewed Disparities Annual review of clinical psychology

    Key finding: This health inequality reflects structural racism, which creates and sustains racial differences in social determinants of health, including education access and quality, economic stability, social and community context, neighborhood and built environment, and health care access and quality. +4 more findings

  19. 2025-01-13

    Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease

    ✓ Peer-reviewed Health systems and care delivery The journal of prevention of Alzheimer's disease

    Key finding: The advancement of disease-modifying treatments (DMTs) for Alzheimer's disease (AD), along with the approval of three amyloid-targeting therapies in the US and several other countries, represents a significant development in the treatment landscape, offering new hope for addressing this once untreatable chronic progressive disease. +2 more findings

  20. 2025-01-13

    Neighborhood environment associations with cognitive function and structural brain measures in older African Americans

    ✓ Peer-reviewed Risk factors BMC medicine

    Key finding: Since older adults spend significant time in their neighborhood environment, environmental factors such as neighborhood socioeconomic disadvantage, high racial segregation, low healthy food availability, low access to recreation, and minimal social engagement may have adverse effects on cognitive function and increase susceptibility to dementia. +4 more findings

  21. 2025-01-13

    Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in Neuroscience

    Key finding: Five weeks of daily IN dosing of Long Evans rats with 15 μL of a 1% (0.3 mg), but not 0.1% (0.03 mg), solution of DFO rescued cognitive impairment caused by ICV STZ administration as assessed with the Morris Water Maze (MWM) test of spatial memory and learning. +3 more findings

  22. 2025-01-13

    Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis

    ✓ Peer-reviewed Inflammation and the immune system Molecular Neurodegeneration

    Key finding: Here, we found that the level of histone deacetylase 7 (HDAC7) was remarkably increased in the astrocytes of AD patients and P301S tau transgenic (PS19) mice. +4 more findings

  23. 2025-01-13

    Mitochondria-derived vesicles: New players in the game of neurodegeneration

    ✓ Peer-reviewed Risk genes beyond APOE Neural Regeneration Research

    Key finding: MDVs are small vesicles that bud from mitochondria and play an important role in removing damaged mitochondrial components. +4 more findings

  24. 2025-01-13

    Neuropsychological and clinical indicators of Lewy body and Alzheimer's pathology

    ✓ Peer-reviewed Lewy body dementia Journal of Alzheimer s Disease Reports

    Key finding: Gait disturbances (odds ratio (OR) = 19.32; p = 0.01), visual-spatial complaints (OR = 6.06; p = 0.03), and visual hallucinations (OR = 31.06; p = 0.002) predicted DLB compared to AD, along with better memory (OR = 3.42; p = 0.003), naming (OR = 3.35; p = 0.002), and worse processing speed (OR = 0.51; p = 0.01). +4 more findings

  25. 2025-01-13

    Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum

    ✓ Peer-reviewed Lewy body dementia JAMA Neurology

    Key finding: Thirty-five patients with probable DLB, 37 patients with MCI-LB, and 100 individuals without cognitive impairment were included. +4 more findings

Browse the library by subject, with the full score breakdown →